Vaccine Marketing - Innovation and Marketing in the Pharmaceutical Industry - page 409

Deer B (2011) How the case against the MMR vaccine was fi xed. BMJ 342
Dekimpe MG, Hanssens DM (1995) Empirical generalizations about market evolution and stationarity.
Mark Sci 14(3):G109-G121
Dekker AH (2006) Fostering acceptance of human papillomavirus vaccines. J Am Osteopath
Assoc 106(3 Suppl 1):S14-S18
Department of Health (2011) The seasonal infl uenza immunisation programme. Consultation: a
review of the procurement of seasonal fl u vaccine. Department of Health, UK. http://consultations.
dh.gov.uk/ . Accessed 23 Aug 2011
DeRoeck D, Bawazir SA, Carrasco P, Kaddar M, Brooks A, Fitzsimmons J et al (2006) Regional
group purchasing of vaccines: review of the pan American health organization EPI revolving
fund and the gulf cooperation council group purchasing program. Int J Health Plann Manage
21(1):23-43
Dhalla S, Poole G (2011) Motivators of enrolment in HIV vaccine trials: a review of HIV vaccine
preparedness studies. AIDS Care 23(11):1430-1447
Downs JS, de Bruin WB, Fischhoff B (2008) Parents' vaccination comprehension and decisions.
Vaccine 26(12):1595-1607
Doyle J, Baumgartner J, Bell J (2010a) HPV vaccine coverage and adoption across the United
States. Value Health 13(3):A47
Doyle J, Baumgartner J, Bell J (2010b) Meningitis vaccine coverage and adoption across the
United States. Value Health 13(3):A194
Dube E, Fannie D, Vladimir G, Julie BA, Chantal S, France L, Francois BD, Shelly M, Ian G,
Nicole B (2011) A(H1N1) pandemic infl uenza and its prevention by vaccination: paediatri-
cians' opinions before and after the beginning of the vaccination campaign. BMC Public
Health 2011:11(128)
Duclos P, Okwo-Bele JM, Salisbury D (2011) Establishing global policy recommendations: the
role of the strategic advisory group of experts on immunization. Expert Rev Vaccines 10(2):
163-173
Endrich MM, Blank PR, Szucs TD (2009) Infl uenza vaccination uptake and socioeconomic deter-
minants in 11 European countries. Vaccine 27(30):4018-4024
Epstude K, Roese NJ (2008) The functional theory of counterfactual thinking. Pers Soc Psychol
Rev 12(2):168-192
Eskola J, Kilpi T (2011) Public-private collaboration in vaccine research. Lancet 378(9789):
385-386
European Commission (2009) Pharmaceutical sector inquiry fi nal report. European Commission,
Brussels
Extance A (2011) Cell-based fl u vaccines ready for US prime time. Nat Rev Drug Discov 10:246
Fine PE, Clarkson JA (1986) Individual versus public priorities in the determination of optimal
vaccination policies. Am J Epidemiol 124(6):1012-1020
Fishbein M, Ajzen I (1975) Belief, attitude, intention, and behavior: an introduction to theory and
research. Addison-Wesley, Reading, MA
Flood EM, Rousculp MD, Ryan KJ, Beusterien KM, Divino VM, Toback SL et al (2010) Parents'
decision-making regarding vaccinating their children against infl uenza: a web-based survey.
Clin Ther 32(8):1448-1467
Frank RG (2001) Prescription drug prices: why do some pay more than others do? Health Aff
20(2):115-128
Freed GL, Cowan AE (2002) State-level perspectives on vaccine purchase fi nancing. http://www.
iom.edu/~/media/Files/Activity%20Files/Disease/VaccineFinancing/FreedandCowan
BackgroundPaper.pdf . Accessed 21 Aug 2011
Freed GL, Cowan AE, Clark SJ (2008a) Primary care physician perspectives on reimbursement for
childhood immunizations. Pediatrics 122(6):1319-1324
Freed GL, Cowan AE, Gregory S, Clark SJ (2008b) Variation in provider vaccine purchase prices
and payer reimbursement. Pediatrics 122(6):1325-1331
Freed GL, Clark SJ, Butchart AT, Singer DC, Davis MM (2010) Parental vaccine safety concerns
in 2009. Pediatrics 125(4):654-659